VCWA
ELOX

Vanguard Capital Wealth Advisors’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Vanguard Capital Wealth Advisors’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,175
Closed -$22K – 132
2022
Q3 		$22K Sell
3,175
-723
-19% -$8.69K 0.03% 112
2022
Q2 		$41K Sell
3,898
-75
-2% -$1.03K 0.05% 125
2022
Q1 		$86K Hold
3,973
– – 0.06% 147
2021
Q4 		$111K Sell
3,973
-6,975
-64% -$304K 0.08% 141
2021
Q3 		$457 Buy
10,948
+7,823
+250% +$482K 0.31% 76
2021
Q2 		$248K Buy
+3,125
New +$261K 0.19% 118

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Vanguard Capital Wealth Advisors's ELOX Position: Q4 2022 in Review

Vanguard Capital Wealth Advisors sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2022, closing a stake of 3,175 shares — an estimated $22K sold.

Vanguard Capital Wealth Advisors first reported a position in ELOX in Q2 2021 and held it in 6 quarters. The position peaked at $248K in Q2 2021. 19 funds tracked by Wall St. Rank hold ELOX as of Q4 2022.

  • Vanguard Capital Wealth Advisors reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Vanguard Capital Wealth Advisors sold 3,175 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $22K.
  • Vanguard Capital Wealth Advisors first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Vanguard Capital Wealth Advisors's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $248K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Vanguard Capital Wealth Advisors's 13F filing for Q4 2022, filed 18 Jan 2023.